Salicylic Acid

Salicylic Acid

SCHEMBL7205746

O=C([O-])c1ccccc1O.[Cu+]

nearest known ligand 0.91

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHE

The experimentally established mechanism targets of Salicylic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.91
▸ HPGD P15428 5/20 0.91
▸ ALDH1A1 P00352 3/20 0.91
▸ SMN1; SMN2 Q16637 2/20 0.58
▸ CA1 P00915 2/20 0.58
▸ CA9 Q16790 2/20 0.58
▸ CA12 O43570 1/20 0.58
▸ CA2 P00918 1/20 0.58
▸ HMGB1 P09429 1/20 0.58
▸ CA4 P22748 1/20 0.58
▸ CA6 P23280 1/20 0.58
▸ CA7 P43166 1/20 0.58
▸ NAPRT Q6XQN6 1/20 0.58
▸ CA14 Q9ULX7 1/20 0.58
▸ HSD17B10 Q99714 3/20 0.56
▸ TSHR P16473 2/20 0.56
▸ MAPT P10636 2/20 0.56
▸ GAA P10253 2/20 0.52
▸ MPO P05164 1/20 0.52
▸ HIF1A Q16665 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Salicylic Acid SCHEMBL28088933 0.98 KDM4E (0.86) KDM4EHPGDALDH1A1SMN1; SMN2CA1
Salicylic Acid SCHEMBL6249450 0.97 KDM4E (0.95) KDM4EHPGDALDH1A1SMN1; SMN2CA1
Salicylic Acid SCHEMBL546852 0.95 KDM4E (0.91) KDM4EHPGDALDH1A1SMN1; SMN2CA1
Salicylic Acid SCHEMBL7738091 0.95 KDM4E (0.91) KDM4EHPGDALDH1A1SMN1; SMN2CA1
Salicylic Acid SCHEMBL2511998 0.95 KDM4E (0.91) KDM4EHPGDALDH1A1SMN1; SMN2CA1
Salicylic Acid SCHEMBL458273 0.95 KDM4E (0.91) KDM4EHPGDALDH1A1SMN1; SMN2CA1
Salicylic Acid SCHEMBL1026592 0.95 KDM4E (0.91) KDM4EHPGDALDH1A1SMN1; SMN2CA1
Salicylic Acid SCHEMBL9981 0.95 KDM4E (0.91) KDM4EHPGDALDH1A1SMN1; SMN2CA1
Salicylic Acid SCHEMBL3132735 0.95 KDM4E (0.91) KDM4EHPGDALDH1A1SMN1; SMN2CA1
Salicylic Acid SCHEMBL11514957 0.95 KDM4E (0.91) KDM4EHPGDALDH1A1SMN1; SMN2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6042848-A FOR CONTROLLING GROWTH OF UNDESIRABLE OR PATHOGENIC MICROORGANISMS IN VARIOUS LOCI OR MILIEU IN, ON, OR OUTSIDE THE BODY EMPLOYING ANTIMICROBIAL PEPTIDES AND METAL IONS THE BOARD OF TRUSTEES OF SOUTHERN ILLINOIS UNIVERSITY (US) 2000-03-28 — — US claimed
EP-0920327-A1 ENHANCEMENT OF ANTIMICROBIAL PEPTIDE ACTIVITY BY METAL IONS Southern Illinois University (US) 1999-06-09 — — EP claimed
WO-1998006419-A1 ENHANCEMENT OF ANTIMICROBIAL PEPTIDE ACTIVITY BY METAL IONS SOUTHERN ILLINOIS UNIVERSITY (US) 1998-02-19 — — WO claimed
EP-0004570-B1 THIOL ESTERS, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND A PROCESS FOR PREPARING CEPHALOSPORIN COMPOUNDS USING THE SAME Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1982-04-14 — — EP claimed
EP-0004570-A1 Thiol esters, process for their preparation, pharmaceutical compositions containing them and a process for preparing cephalosporin compounds using the same Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1979-10-17 — — EP claimed
EP-2709714-B1 APPARATUS FOR HEATING A TREATMENT REGION WITH AN ALTERNATING ELECTRIC FIELD INNOVOLINK LLC (US) 2019-01-16 — — EP disclosed
US-9956028-B2 Apparatus and method for heating biological targets INNOVOLINK, LLC (US) 2018-05-01 — — US disclosed
US-9901387-B2 Apparatus and method for heating adipose cells INNOVOLINK, LLC (US) 2018-02-27 — — US disclosed
US-9901742-B2 Apparatus and method for heating a treatment region with an alternating electric field INNOVOLINK, LLC (US) 2018-02-27 — — US disclosed
US-9675814-B2 Apparatus and method for obtaining a substantially constant current across a treatment region INNOVOLINK, LLC (US) 2017-06-13 — — US disclosed
US-20150309434-A1 POLYMER PARTICLES AND METHOD FOR PRODUCING A THREE-DIMENSIONAL STRUCTURE THEREFROM BY MEANS OF AN ELECTROGRAPHIC METHOD Universität Stuttgart (DE) 2015-10-29 — — US disclosed
US-9098000-B2 Process of making a three-dimensional structure on a support structure FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) 2015-08-04 — — US disclosed
WO-1998006419-A1 ENHANCEMENT OF ANTIMICROBIAL PEPTIDE ACTIVITY BY METAL IONS SOUTHERN ILLINOIS UNIVERSITY (US) 1998-02-19 — — WO disclosed
US-4767704-A CULTIVATING HYBRIDOMAS; TRACE ELEMENTS, INORGANIC SALTS AND BASAL MEDIUM COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 1988-08-30 — — US disclosed
US-4639308-A RECYCLING GASES AFTER REMOVAL OF OLEFINS PHILLIPS PETROLEUM COMPANY (US) 1987-01-27 — — US disclosed
EP-0004570-B1 THIOL ESTERS, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND A PROCESS FOR PREPARING CEPHALOSPORIN COMPOUNDS USING THE SAME Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1982-04-14 — — EP disclosed
US-4314059-A Process for preparing cephalosporin compounds SHIBUYA CHISEI 1982-02-02 — — US disclosed
US-4258195-A Novel thiol esters and process for preparing cephalosporin compounds using same ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1981-03-24 — — US disclosed
US-4226792-A BALLISTICS PROPELLANT ADDITIVE NL INDUSTRIES, INC. (US) 1980-10-07 — — US disclosed
EP-0004570-A1 Thiol esters, process for their preparation, pharmaceutical compositions containing them and a process for preparing cephalosporin compounds using the same Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1979-10-17 — — EP disclosed
Send feedback